Group 1 - Autonomix Medical, Inc. is a medical device company focused on advancing precision nerve-targeted treatments, participating in the Virtual Investor "Top 5 for '25" On-Demand Conference [2][3] - The company's technology includes a catheter-based microchip sensing array that can detect and differentiate neural signals with approximately 3,000 times greater sensitivity than current technologies [4] - Initial development of this technology targets pain treatment, specifically for pancreatic cancer, which is known for causing debilitating pain and lacks reliable solutions [5] Group 2 - The technology platform has the potential to address various indications, including cardiology, hypertension, and chronic pain management, across a wide disease spectrum [5] - The technology is currently investigational and has not yet received marketing clearance in the United States [5] - For further information, the company encourages connections through its website and social media platforms [6]
Autonomix Medical, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference